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I n patients with structural heart disease (SHD), defined by the presence of myocardial scarring either on cardiac imaging or electroanatomical mapping, catheter ablation is increasingly used for the treatment of ventricular tachycardia (VT).
With more detailed knowledge of potential substrates and anatomic structures involved in VT, not only the endocardium of the left ventricle (LV) and right ventricle (RV) but also more complex structures like the aortic root, the cardiac veins, or the epicardium have become areas of interest for ablation.
Preprocedural analysis of the clinically documented VT 12-lead ECG is often used to predict the VT site of origin (SoO), and it is considered to be an important tool for planning the ablation, to estimate the probability of success, and to recognize potential procedural limitations and related risks. These factors may have important implications not only for patient advice and decision making but also for the selection of a center capable to perform the expected procedure.
Because the majority of inducible VTs in patients with SHD are not hemodynamically tolerated, 1,2 a detailed analysis of the VT 12-lead ECG of each induced VT may also be helpful. Combining the ECG with information of the scar size and distribution obtained from electroanatomical mapping during sinus rhythm or from preprocedural imaging may direct mapping to the area of interest with the potential of increasing procedural success and to reduce procedural duration.
In this review, we will focus on the reported evidence for the value of the 12-lead VT ECG as a mapping tool in patients with scar-related VT and discuss its potential implications when combined with scar information from electroanatomical mapping or imaging.
VT SoO
The mechanism of the majority of VTs in patients with structurally normal hearts is focal, and the 12-lead ECG can be helpful to predict its SoO because rapid activation of the normal myocardium from a focal source results in typical QRS patterns. 3 As a general rule, VTs originating from the structurally normal LV have a right bundle branch block (RBBB) morphology (defined as predominant R in lead V1) and VTs from the normal RV have a left bundle branch block (LBBB) morphology (defined as predominant S in lead V1). The precordial transition for RBBB VTs (first lead with a predominant S) changes from positive concordant for VTs originating from the base of the LV to progressively earlier transition in V2-V4 as the VT origin moves toward the apex of the ventricle. For LBBB VTs, VTs originating from the basoseptal area of the RV have an early transition (first lead with a predominant R), and the transition becomes progressively later as the VT origin moves toward the ventricular free wall. With regard to the frontal plane axis, VTs originating from the superior aspect of the ventricles show an inferior axis (predominant R in aVF), VTs from the inferior aspect of the ventricles show a superior axis (predominant S in aVF), LV free wall VTs have typically a right axis (with a dominant S in I and aVL), and septal VTs typically have a left axis (with a dominant R in I and aVL). Finally, septal VTs have a narrower QRS than VTs from the ventricular free wall.
In contrast to patients with structurally normal hearts, the majority of VTs in patients with SHD are because of scarrelated re-entry. The SoO of a scar-related re-entrant VT has been differently defined as (1) the VT exit site, from which the normal myocardium is rapidly activated, which corresponds to the scar border and coincides with the QRS onset on the surface ECG 4-7 ; (2) the re-entry circuit exit site from which the activation wavefront emerges from the critical slow conducting VT isthmus, which may not necessarily correspond to the scar border and may precede the activation of the rapidly conducting myocardium with only little effect on the 12-lead ECG; or (3) the target site for ablation, usually defined as the critical slow conducting VT isthmus, which is activated during diastole, thereby not contributing to the surface ECG at all. 8 The 12-lead ECG morphology of a scar-related re-entrant VT depends mainly on the VT exit site, or the site(s) or the area(s) from which the normal myocardium is activated. Thus, only if the re-entry circuit exit site coincides with the scar border, the 12-lead VT ECG may be helpful to directly guide to the area of interest for ablation ( Figure 1 ; Case 1 in the Data Supplement).
Furthermore, the overall size and distribution of the scar and the size, distribution, and properties of the remote myocardium determine the overall 12-lead VT ECG morphology. Therefore, in patients with large scars, the accuracy of the 12-lead ECG to localize the VT SoO may be limited also for tachycardias with a focal mechanism.
Value of the 12-Lead ECG to Predict the Endocardial VT SoO in Patients With Previous Myocardial Infarction

SoO as Exit Site
In the pioneering work of Miller et al, 4 the VT SoO was defined as the earliest recorded activity on the second half of the diastole during endocardial VT activation mapping. All 182 mapped VTs from 102 patients with single previous myocardial infarction (MI) had 1 endocardial site activated at least 40 ms before the QRS onset. Each 12-lead ECG of VT was categorized according to the location of the MI (anterior or inferior), the BBB type configuration, the frontal plane axis, and 1 of 8 prespecified precordial R-wave progression patterns ( Figure 2A) . A specific morphology of VT was defined as a characteristic morphology (based on the combination of these 4 factors) that was associated with 1 of 11 predefined LV regions based on fluoroscopy with a positive predictive value of >70% ( Figure 2B ).
Of the 128 VTs in 73 patients with anterior MI, only 47 (37%) had such a specific morphology. Fifty VTs (39%) had an LBBB morphology, suggesting a septal VT exit site. Among the LBBB VTs, 37 (74%) had 1 of 2 identified specific patterns: 90% of the VTs with a left superior axis and a late or no transition were mapped to the inferoapical septum, and the majority of VTs (81%) with inferior axis regardless of the precordial pattern were mapped to the anteroapical septum (Case 2 in the Data Supplement). Of the 78 VTs (61%) with an RBBB morphology, only 10 (13%) had a specific morphology: 7 of 10 VTs (70%) that had a right inferior axis and either dominant or abrupt loss precordial pattern were also related to the anteroapical septum ( Figure 2C ).
For inferior MI, the results were better. In 40 of 54 VTs (73%) from 35 patients, a specific morphology could be identified. Of the 23 VTs (43%) with an LBBB morphology, 88% of those with left superior axis and a growing precordial pattern were mapped to the inferobasal septum. Thirty-one VTs had an RBBB morphology (57%), and of them, 2 specific morphologies could be determined: 14 of 16 VTs (88%) with superior axis and either an early or late reverse precordial pattern were mapped to the inferobasal free wall, whereas 8 of 9 VTs (75%; Case 3 in the Data Supplement) with right inferior axis and a late reverse precordial pattern were mapped to the inferolateral wall ( Figure 2D ).
In this study, an association between a specific 12-lead ECG VT morphology and 1 of the 11 predefined LV regions could only be found for 48% of the mapped VTs. Specific morphologies were more often identified in patients with inferior infarction and for VTs with an LBBB morphology. In patients with anterior MI, only apicoseptal exit sites could be correctly identified.
The algorithm was developed before the advent of electroanatomical mapping and delayed enhancement magnetic resonance imaging (MRI) to delineate scar. Accordingly, it could not correct for variations in anterior and lateral scar extension, which may explain the lack of additional identified specific patterns, in particular, for RBBB VTs after anterior MI (Cases 4 and 5 in the Data Supplement). In contrast, scar extension in inferior MI may be less variable, as these scars are often restricted to the basal inferoseptal and posterior regions with the mitral annulus as 1 common boundary. The limited mapping density, with on average 9 catheter positions using a catheter with a 1-cm tip electrode and an interelectrode spacing of 5 mm, may have also reduced the accuracy of the algorithm. The broad definition of a VT exit site applied in this study may encompass not only VT exit sites from the scar border zone and VT re-entrant circuit exit sites but also critical isthmus sites, which may further influence the predictive value of the algorithm for a specific location. Of note, the RV as a potential SoO was not included, which may contain re-entry circuit and scar exit sites (Case 2 in the Data Supplement).
On the basis of the assumption that pacing at the VT endocardial exit site may generate a QRS morphology identical to the VT morphology, Kuchar et al 5 proposed a different algorithm for localizing the VT SoO. They used ventricular pacemapping as surrogate for a VT exit site. Ninety-three 12-lead ECGs recorded during pacing from different sites in 22 patients with single or multiple previous MI were analyzed and correlated with 1 of 24 LV regions based on fluoroscopy. Five paced QRS complex features could be related or were exclusive for a particular region: (1) a negative QRS in precordial lead V1 was typical for septal sites, but it was never observed during pacing at lateral LV sites; (2) the QRS in A B Figure 1 . A, Schematic representation of a ventricular tachycardia (VT) re-entry circuit. The re-entry circuit exit site corresponds to the scar border zone. Rapid activation (indicated by large arrows) of the normal myocardium determines the VT QRS morphology. Pacing at the scar exit site will likely resemble the VT morphology. B, Schematic representation of a complex scar with 1 potential VT re-entry circuit. The re-entry circuit is located within the scar. The wavefront emerges from the exit of the re-entry circuit isthmus and propagates through multiple small pathways activating the remaining normal myocardium from different sites giving rise to a fused QRS complex. In this case, the VT morphology may not help to predict the scar exit site. precordial lead V4 was never negative by pacing at the basal LV and never positive when pacing at apical regions; (3) a positive QRS in lead I was never observed when pacing from the lateral LV; (4) a predominant negative QRS in lead aVL was observed when pacing from the lateral LV and a predominant positive QRS in lead aVL when pacing from the septum; and (5) a positive QRS in lead II was never observed during pacing from inferior sites. From these data, an algorithm was derived and subsequently tested in 44 induced VTs from 42 additional patients in which the VT SoO could be determined by activation mapping ( Figure 3 ). Precise localization of the endocardial VT exit site using this algorithm was only possible for 39% of the VTs. The algorithm showed a high accuracy (80%-90%) to distinguish between anterior, inferior, septal, and lateral LV regions, but it was not useful to predict central and midventricular sites and was only moderately successful in differentiating sites in the long axis of the ventricle (eg, basal versus apical; 55%-70%).
As for the algorithm of Miller et al, 4 the size and extension of the scar may significantly influence the accuracy of the algorithm to predict the VT SoO. Moreover, pacing at the scar border zone and at potential critical isthmus sites within the scar may not necessarily result in the same 12-lead ECG morphology with different stimulus to QRS intervals than the VT ECG. In particular, for small scars, activation patterns during pacing may be different from the propagation during VT because re-entry circuits may also be determined by the areas of functional block only present during VT. In these cases, a 12/12-lead pace match of the VT ECG cannot be achieved. For large scars, de Chillou et al 9 recently demonstrated that the best match between the paced QRS morphology and the VT morphology could be obtained if pacing was performed at the VT exit region or toward the exit part of the critical VT isthmus. In contrast, pacing at the VT entrance region or at the entrance part of the critical VT isthmus resulted in a completely different QRS complex morphology because of the activation of the preserved myocardium in the opposite direction than during VT. Despite this limitation, careful comparison of the paced ECG morphologies with the VT ECG may still be useful to determine the area of interest if combined with the electroanatomical scar information (Case 3 in the Data Supplement). In addition, pacing at longer cycle length than VT cycle length may also significantly influence the 12-lead ECG. In the study by Kuchar et al, 5 a fixed pacing rate of 400 ms was used, which may also partly explain the low predictive value of the algorithm to precisely localize the VT SoO.
In 2007, Segal et al 6 correlated 12-lead ECG characteristics during VT with VT exit site determined by noncontact mapping. VT ECGs were categorized according to BBB configuration, frontal plane axis, and R-wave transition. The VT exit site was defined as the point from which the rapidly expanding systolic activation on the isopotential map occurred synchronously or just before (≤40 ms) QRS onset and was allocated to 9 predefined LV segments based on the 3-dimensional (3D) reconstruction of the endocardial LV surface using the Ensite system (Ensite 3000; Endocardial Solutions, Inc, St Paul, MN).
A total of 121 VTs from 51 patients with previous (single or multiple) MI were analyzed. All VT ECGs could be categorized in 10 ECG patterns, from which, 8 accounting for 86 VTs (71%) had a positive predictive value of ≥70% for a predefined VT exit site region. Only the BBB morphology and the frontal plane axis were used in the construction of this algorithm because no consistent R-wave precordial transition pattern could be identified ( Table 1 ). All LBBB VTs had a septal exit site, and in contrast to Miller et al, 4 a positive predictive value of ≥70% was more common for RBBB than for LBBB VTs (76% versus 43%). Rapid activation was often recorded from the mid LV regions that are less often involved in either anterior-apical or inferior-basal infarctions. VT exit sites were therefore likely to correspond to the true scar border zone.
The application of distinct definitions for the VT SoO and the inclusion of different patient populations with different scar characteristics among studies (eg, single previous MI in the study by Miller et al 4 More recently, the University of Michigan's group 7 demonstrated that the value of the 12-lead VT ECG for localizing the VT exit site improves substantially when using an automated computerized algorithm. To create the algorithm, digitalized 12-lead ECGs of pacemaps from the scar area of 34 patients with previous MI and the locations of the pacemaps based on a 10-LV region model were used. Subsequently, the training data containing only pacemaps were validated by using the 12-lead ECGs of 58 VTs from 33 patients with post-MI in which the VT exit site was determined by pacemapping. The accuracy of the algorithm for assigning both the 12-lead ECG of pacemaps from the training sample and the VTs of the testing sample to the correct anatomic region was ≈70% (in comparison with an estimated accuracy of 19% for the algorithm of Miller et al 4 and 36% for the algorithm of Segal et al 6 ) with a spatial resolution of 15 cm 2 . The accuracy of the algorithm varied from region to region, and in contrast to the algorithm of Miller et al, 4 it was higher for anterior infarcts and worse for apical regions (≈50%).
In all previously commented studies, the training cohort to create the algorithms differed from the validation cohort. This approach precludes correction for interindividual variations like LV and RV anatomy, rotation of the heart, or lead placement, 10 which may have also contributed to their limited accuracy to predict the VT SoO. Table 2 summarizes the proposed algorithms to identify the endocardial VT SoO in patients with previous MI.
SoO as Target Site for Ablation
Activation of the slow conducting critical isthmus does not often directly contribute to the 12-lead VT ECG. However, the combination of different 12-lead VT morphologies inducible in 1 patient may provide important, although indirect, information for the location of an ablation target site. Wilber et al 8 demonstrated that in patients with previous inferior MI inducible for 2 specific VT morphologies, 1 with LBBB and left superior axis and the other with RBBB and right superior axis, the critical isthmus site for both VTs can be located in the inferobasal LV, close to the mitral annulus. In this study, 4 of 12 patients after inferior MI had these 2 inducible VT morphologies. In each of these 4 patients, participation of this mitral isthmus as critical slow conducting part of the reentrant circuit was demonstrated during both RBBB and LBBB tachycardias by entrainment mapping. A single radiofrequency application abolished both VT morphologies, suggesting that this critical site was shared by both VTs (Figure 4 ). Of interest, the BBB configuration and the frontal plane axis of the VTs were consistent among the 4 patients. However, some important differences in the precordial patterns were observed, suggesting that in particular, the precordial leads are more influenced by interindividual variations, such as the shape of the heart and scar distribution ( Figure 5 ). With increasing septal scar extension, also LBBB VTs with early precordial transition and inferior axis can be related to a mitral isthmus re-entry circuit (Figure 5, patient 4 ). In addition, with more apical scar extension, the precordial transition of RBBB VTs to a dominant negative QRS complex may be observed in V4 despite a basolateral exit site ( Figure 5, patients 1 and 3 ).
Value of the 12-Lead ECG to Predict an Epicardial Versus an Endocardial LV VT SoO
Previous Reports
Critical parts of the re-entrant circuit that are located deep in the myocardium or at the subepicardium can often not be abolished by endocardial ablation. This is more common in patients with nonischemic cardiomyopathy (NICM), in which the VT substrate is frequently located intramurally or subepicardially, often requiring an epicardial or a combined endoepicardial ablation to achieve procedural success. 11, 12 Delayed enhancement MRI performed before mapping and ablation can delineate the 3D scar geometry and its relationship with the endocardial and epicardial surfaces. On the basis of the MRI-derived scar information, patients who may benefit from an endocardial, epicardial, or combined approach can be selected. 13 However, currently, MRI imaging in patients with implanted defibrillators is only available at selected centers. In addition, artifacts because of leads and pulse generators may hamper detailed analysis of, in particular, anterior basal segments. 14 Electroanatomical voltage mapping may be an alternative to detect myocardial scar. However, endocardial bipolar voltage mapping is limited by the presence of endocardial viable myocardium in patients with midmyocardial or subepicardial scars. 15 The value of endocardial unipolar voltage mapping to unmask epicardial scars has been recently suggested. 16 However, if compared with delayed enhancement MRI, unipolar endocardial voltage mapping has only a moderate sensitivity and specificity for detecting subepicardial scars. 17 Using the 12-lead ECG of the VT to determine the required access is appealing. Berruezo et al 18 were the first to propose ECG criteria to distinguish an epicardial from an endocardial LV VT SoO in a mixed group of patients with ischemic and NICM. All criteria are based on the assumption that ventricular activation originating from the epicardium is followed by a transmural activation delay until the subendocardial Purkinje system is reached. This propagation pattern will prolong the initial part of the QRS resulting in visible slurring or widening.
LBBB VTs were excluded from the initial analysis as these VTs were considered to originate from the interventricular septum.
A pseudodelta wave, ≥34 ms: interval from the earliest ventricular activation to the earliest rapid deflection in (PM1, A) . The best pacemap for VT2 was found in the basoseptal aspect of the scar (PM2, B) . The successful ablation site for both VTs located in the basal LV close to the mitral annulus (MA) is indicated with a white dot. The blue arrows indicate the assumed direction of the activation wavefront during VT1 and VT2, respectively. INF indicates inferior; and RAO, right anterior oblique.
any precordial lead; an intrinsicoid deflection time, ≥85 ms: interval from the earliest ventricular activation to the peak of the R wave in V2; and the shortest RS complex, ≥121 ms: interval from the earliest ventricular activation to the nadir of the first S wave in any precordial lead predicted the failure of an endocardial VT ablation with a high sensitivity and specificity in patients with SHD (Case 6 in the Data Supplement). Following the same concept, Daniels et al 19 showed that a maximum deflection index of ≥55 ms, defined as the interval from the earliest ventricular activation to the peak of the largest amplitude deflection in each precordial lead (taking the lead with the shortest time) divided by the QRS duration, identified an epicardial VT origin with a high sensitivity and specificity (>95%) in patients with idiopathic VTs with both RBBB and LBBB morphologies ( Figure 6 ).
Bazan et al 20 reported that these previously suggested interval criteria, although useful to identify an epicardial LV-VT SoO, did not perform uniformly for all LV regions. Additional site-specific morphological criteria were proposed based on the concept that the initial vector of impulse propagation from the epicardium toward the endocardium would result in the presence of an initial Q wave in the ECG leads reflecting the site of epicardial activation (or the absence of a Q wave in opposite leads). A Q wave in lead I for basal superior and apical superior VTs was associated with an epicardial SoO. In addition, the absence of Q waves in any inferior leads for basal superior VT or a Q wave in inferior leads with VTs arising from the basal inferior and apical inferior LV also indicated an epicardial SoO.
Because the substrate for VTs in patients with NICM is often located in the basal LV, clustering around the mitral and aortic annulus, Vallès et al, 21 from the same group, evaluated the value of the previously proposed interval and morphological criteria to predict an epicardial VT origin from this specific LV region. Of 24 VTs with an RBBB morphology originated in the basal superior or lateral LV from 14 patients with NICM, 16 had an epicardial origin on the basis of entrainment or pace-mapping. Applying the interval ECG criteria, only a significantly longer duration of the QRS and a longer shortest RS complex were observed for epicardial compared with endocardial VTs. Of note, the presence of a Q wave in lead I had the highest individual sensitivity and specificity (88%) of all tested criteria. However, because a single criterion had a limited predictive value, a 4-step algorithm that included interval and morphological criteria was proposed reaching a high sensitivity and specificity for identifying an epicardial VT SoO from the basal or lateral LV in the preselected group of patients with NICM ( Figure 7) .
Recently, Yokokawa et al 22 demonstrated that the accuracy of the 12-lead ECG for differentiating between endocardial and epicardial pace-map sites improved when applying a computerized algorithm compared with previous reported algorithms.
Limitations of the 12-Lead ECG to Predict an Epicardial VT SoO
The ECG criteria for identifying an epicardial LV VT SoO were derived from the analysis of pacemaps and a limited number of VTs from a population mainly comprised of patients without SHD or with NICM (Table 3 ). Martinek et al 23 showed that in patients with post-MI, both the interval and the morphological ECG criteria failed to distinguish an epicardial from an endocardial LV VT SoO defined as the successful ablation site. Two factors may explain this finding. The presence of typical Q waves in the VT ECGs of patients with previous MI precludes the use of morphological ECG criteria, and when present in the precordial leads, Q waves may interfere with the measurement of all interval criteria (Case 6 in the Data Supplement). Perhaps even more importantly, the VT 12-lead ECG provides information about the VT exit site from the scar border, but successful ablation is often performed at other critical parts of the re-entrant circuit. In particular, in patients with previous MI, both the presence of wall thinning and the subendocardial location of parts of the re-entry circuit may allow successful ablation of VTs with an epicardial exit site from the endocardium. Accordingly, the number of VTs with an epicardial exit site may be underestimated. However, for induced VTs, the morphological criteria seemed to be not affected by the VT cycle length or amiodarone use. The latter confirms the findings from Vallès et al, 21 who, as previously stated, demonstrated that the presence of a Q wave in lead I had the highest individual accuracy for identifying an epicardial VT origin in patients with NICM ( Figure 8 ).
There are limited data on the value of the 12-lead VT ECG to predict an epicardial VT origin from the RV. Bazan et al 25 analyzed 180 endocardial and 134 epicardial pacemaps from a group of 13 patients without SHD (7/13) and RV cardiomyopathy (8/13). No interval criterion was able to distinguish an epicardial from an endocardial RV pacemap site in this population. Again, site-specific morphological criteria seemed to be useful for identifying an epicardial RV pace-map site. However, this finding was based on only 5 successfully ablated VTs from the epicardial RV. 
Value of the 12-Lead ECG to Predict the Underlying Substrate for VT
In patients with NICM, the VT 12-lead ECG morphology helps to predict the location and extension of the arrhythmogenic substrate, which may have implications for selecting the primary ablation approach (endocardial versus endo/epicardial) and for estimating the probability of procedural success and patient prognosis. Piers et al 17 demonstrated that 17 of 19 patients (89%) with NICM referred for VT ablation with delayed enhancement MRI integration had 1 of 2 typical scar patterns (basal anteroseptal or inferolateral). All but 1 patient had at least 1 of 3 characteristic VT ECG morphologies, diagnostic for 1 of these 2 typical scar locations. All patients with an RBBB morphology, positive precordial concordance and inferior axis VTs or an LBBB morphology, early precordial transition (≤V3), and inferior axis VTs had an anteroseptal scar, whereas all patients with an RBBB morphology, late precordial transition, and right (superior or inferior) axis VTs had an inferolateral scar (Figure 9 ). The majority of ablation target sites for patients with anteroseptal scars were located in the aortic root or in the basal anteroseptal LV endocardium (Case 7 in the Data Supplement). In these patients, if ablation via the coronary sinus and its branches fails, epicardial mapping and ablation using a conventional subxiphoid approach are unlikely to be appropriate because of the presence of the overlying left atrial appendage, coronary arteries, or epicardial fat at the epicardial LV summit. On the contrary, in patients with inferolateral scars, the majority of ablation target sites could be reached from the LV epicardium. Epicardial mapping was not hampered by overlying structures like the left atrial appendage, a thick fat layer, or coronary arteries in these patients; however, radiofrequency delivery may need to be withheld if damage of the coronary arteries or the phrenic nerve cannot be excluded. Oloriz et al 26 confirmed subsequently these findings in a larger cohort of patients.
As previously indicated, the VT substrate in patient with NICM is often located in the basal LV, around the valvular annuli with variable extension toward the LV apex. Of 76 patients with NICM referred for VT ablation, Frankel et al 27 identified 32 (42%) who had spontaneous or induced VTs with a morphology suggestive of an apical exit site. An apical VT morphology was defined as a VT with an LBBB morphology and late precordial transition (≥V5) to a dominant positive QRS complex or with an RBBB morphology and early precordial transition (≤V3) to a dominant negative QRS complex. Markedly, patients with apical VT morphologies had larger scar areas delineated by voltage mapping and a worse prognosis, with a higher likelihood of requiring heart transplant or LV assist devices because of advanced heart failure.
Finally, data on the value of the 12-lead ECG for predicting the underlying substrate for VTs arising from the RV are scarce. Hoffmayer et al 28 compared the 12-lead ECG morphology of VTs with LBBB and inferior axis from 42 patients with idiopathic RV outflow tract VT and 16 with arrhythmogenic RV cardiomyopathy. The duration of the QRS in lead I ≥120 ms, earliest onset of QRS in lead V1, presence of QRS notching in at least 1 lead, and a precordial transition at V 5 or later were independent predictors of arrhythmogenic RV cardiomyopathy. Using these ECG features during VT and the presence/absence of negative T waves in leads V1-V3 during sinus rhythm, the same authors constructed a risk score for arrhythmogenic RV cardiomyopathy. 29 A score of ≥5 (maximum score, 8 points) identified arrhythmogenic RV cardiomyopathy as underlying substrate for VT with a positive predictive value of 100% and a negative PV of 91%.
Summary
Several algorithms for identifying the VT origin based on the analysis of the 12-lead VT ECG have been suggested. These algorithms have applied different definitions for VT SoO that include not only VT exit sites but also re-entry circuit exit sites and isthmus sites. In addition, they have been validated by different mapping techniques encompassing not only activation and entrainment mapping but also pacemapping. None of the algorithms integrated information on the scar extension and distribution, which may increase the accuracy of the ECG to precisely predict the VT origin. A systematic re-evaluation of the value of the 12-lead ECG for VT ablation in the context of 3D electroanatomical mapping, scar imaging, and changing ablation strategies with a shift from targeting clinical and induced VTs to substrate ablation approaches is needed.
